chevron_leftBack
As of 13 June 2026, Burzynski Research Institute, Inc. has a market cap of $1.77M USD, ranking #47451 globally and #6037 in the United States.
It ranks #4209 in the Healthcare sector, and #326 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$1.77MUSD
Enterprise Value
$1.77MUSD
Net Income (TTM)
-$1.29MUSD
PB Ratio
-26.4
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Stanislaw Burzynski
open_in_new
Employees
1
Founded
1977
Website
propcitweb.ddns.net:83
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -30% | -7.6% | -4.4% | -14% | -58% | -47% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
BZYR
Burzynski Research Institute Inc
ISIN: US1231591058
Shares Out.:
Shares Outstanding:
131.448M1
Shares Float:
24.968M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.0135 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Burzynski Research Institute, Inc.
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: RVMD
|
$29.56B
2M%
|
-
|
|
LSE: INDV
|
$2.07B
117K%
1.54B GBP
|
-
|
|
OTCMKTS: NDOI
|
$1.8B
101K%
|
0.4
|
|
NASDAQ: DVAX
|
$1.76B
99K%
|
-
|
|
NASDAQ: AVBP
|
$1.33B
75K%
|
-
|
|
NYSE: BRBR
|
$1.02B
58K%
|
12.1
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$36.75B
2M%
108.92B ILS
|
24.2
|
|
SHE: 002001
|
$15.84B
893K%
107.34B CNY
|
16.0
|
|
NSE: CIPLA
|
$11.16B
629K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.04B
622K%
1.05T INR
|
22.7
|
|
SHE: 002653
|
$9.09B
512K%
61.6B CNY
|
80.6
|
|
EPA: ABVX
|
$8.74B
493K%
7.57B EUR
|
-
|
chevron_leftBack